切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2021, Vol. 11 ›› Issue (06) : 263 -267. doi: 10.3877/cma.j.issn.2095-2015.2021.06.004

临床研究

肝窦阻塞综合征患者临床及影像学表现分析
李惠贞1, 蔡剑鸣1, 董景辉1, 刘渊1, 任洪伟1, 安维民1,()   
  1. 1. 100039 北京,解放军总医院第五医学中心放射诊断科
  • 收稿日期:2021-06-08 出版日期:2021-12-01
  • 通信作者: 安维民

Clinical and imaging analysis of patients with hepatic sinusoidal obstruction syndrome

Huizhen Li1, Jianming Cai1, Jinghui Dong1, Yuan Liu1, Hongwei Ren1, Weimin An1,()   

  1. 1. Department of Radiology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
  • Received:2021-06-08 Published:2021-12-01
  • Corresponding author: Weimin An
引用本文:

李惠贞, 蔡剑鸣, 董景辉, 刘渊, 任洪伟, 安维民. 肝窦阻塞综合征患者临床及影像学表现分析[J]. 中华消化病与影像杂志(电子版), 2021, 11(06): 263-267.

Huizhen Li, Jianming Cai, Jinghui Dong, Yuan Liu, Hongwei Ren, Weimin An. Clinical and imaging analysis of patients with hepatic sinusoidal obstruction syndrome[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2021, 11(06): 263-267.

目的

分析肝窦阻塞综合征(HSOS)患者临床及影像学表现(CT或MR),提高对本病的诊断水平。

方法

回顾性分析2010年11月至2019年11月解放军总医院第五医学中心收治的40例HSOS患者的发病原因、临床表现、实验室检查及影像学表现。

结果

40例HSOS患者中,31例有明确的药物服用史,以服用"土三七"者最多,占65.0%(26/40),5例为肝移植术后,1例为肾移植术后,3例病因不明。主要临床表现为腹胀、乏力、腹水等。实验室检查以天冬氨酸氨基转移酶(AST)、γ-谷氨酰基转移酶(GGT)、总胆红素(TBil)及直接胆红素(DBil)水平升高为主,分别占60.0%(24/40)、77.5%(31/40)、75.0%(30/40)、87.5%(35/40),同时96.4%(27/28)的患者糖类抗原125(CA125)水平升高显著,D-二聚体水平升高较为常见(95.2%,20/21)。影像学表现为肝脏弥漫性肿大,增强扫描肝实质呈"花斑样""地图状"不均匀强化,延迟期强化明显,肝静脉周围肝实质强化程度较高,表现为特征性的"三叶草征",肝静脉狭窄或显示不清,下腔静脉受压变细,同时常合并有腹水、胸腔积液及胆囊炎等肝外征象。

结论

HSOS发病原因多样,以服用"土三七"为主,结合患者的发病原因、临床表现、实验室检查及影像学表现,可对该病做出正确诊断。

Objective

To explore the clinical and imaging manifestations (CT or MR) of hepatic sinusoidal obstruction syndrome (HSOS), and improve the diagnosis of this disease.

Methods

The etiology, clinical manifestations, laboratory examinations and imaging findings of 40 HSOS patients admitted to the Fifth Medical Center of the PLA General Hospital from November 2010 to November 2019 were retrospectively analyzed.

Results

Among the 40 HSOS patients, 31 had a clear history of drug use. Among them, "Tusanqi" took the most, accounting for 65.0%(26/40). Five cases were after liver transplantation, 1 case was after kidney transplantation, and 3 cases had unknown etiology. The main clinical manifestations were abdominal distension, fatigue, ascites, etc. In laboratory tests, the levels of aspartate aminotransferase (AST), γ-glutamyltransferase (GGT), total bilirubin (TBil) and direct bilirubin (DBil) were mainly increased, accounting for 60.0% (24/40), 77.5% (31/40), 75.0% (30/40) and 87.5% (35/40), respectively. Meanwhile, the level of carbohydrate antigen 125 (CA125) was significantly increased in 96.4%(27/28) patients, and elevated D-dimer levels were more common (95.2%, 20/21). Imaging manifestations showed diffuse enlargement of the liver. The enhanced scanning showed liver parenchyma "plate-like" and "map-like" uneven enhancement, obvious enhancement in delayed phase, high degree of enhancement of liver parenchyma around hepatic veins, showing characteristic "clover sign", hepatic vein stenosis or unclear display, compression inferior vena cava and thinning, often accompanied by ascites, pleural fluid, cholecystitis and other extrahepatic signs.

Conclusions

There are various causes of HSOS, and the main reason is taking "Tusanqi". Combined with the causes of the disease, clinical manifestations, laboratory examination and imaging manifestations, the correct diagnosis of the disease can be made.

表1 HSOS的诊断标准
图1 肝窦阻塞征患者影像学及病理表现。图A为CT平扫示肝脏增大,肝实质密度不均匀稍减低;图B为CT增强动脉期示肝实质呈"斑片状"强化;图C为CT增强门脉期示肝静脉周围明显强化,呈特征性"三叶草征"(黑色箭头所示),肝静脉显示欠清,同时可见食管静脉曲张(红色箭头所示);图D为CT增强延迟期冠状位示下腔静脉肝内段明显变窄(黑色箭头所示);图E为MRI增强延迟期示肝静脉变窄,显示较CT清晰;图F为病理检查显示以肝腺泡Ⅲ区为主的肝窦内皮细胞的肿胀、损伤、脱落,肝窦可见显著扩张充血(HE染色,×100)
1
Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome [J]. J Dig Dis, 2014, 15(3): 105-107.
2
McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients [J]. Ann Intem Med, 1993, 118(4): 255-267.
3
Jones RJ, Lee KS, Beschomer WE, et al. Venoocclusive disease of the liver following bone marrow transplantation [J]. Transplantation, 1987, 44(6): 778-783.
4
中华医学会消化病学分会肝胆疾病协作组.吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京) [J].临床肝胆病杂志, 2017, 33(9): 1627-1637.
5
de Lédinghen V, Villate A, Robin M, et al. Sinusoidal obstruction syndrome [J]. Clin Res Hepatol Gastroenterol, 2020, 44(4): 480-485.
6
刘建伟,逄菲,王青.吡咯生物碱相关肝窦阻塞综合征1例报道[J].胃肠病学和肝病学杂志, 2020, 29(5): 593-595.
7
李胤蒴,保洁,徐芸. 16例吡咯生物烷生物碱相关肝窦阻塞综合征的临床病理分析[J].中华肝脏病杂志, 2020, 28(4): 332-337.
8
任晓非,诸葛宇征,陈世耀,等.土三七相关肝窦阻塞综合征的全国多中心临床调研分析[J].中华消化杂志, 2017, 37(8): 523-529.
9
王峻瑶,张国艳,朱元民,等.肝窦阻塞综合征9例的临床分析[J].首都医科大学学报, 2014, 35(5): 604-607.
10
Agrawal V, Ranganath P, Ervin KD, et al. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome [J]. Bone Marrow Transplant, 2021, 56(1): 121-128.
11
郭严,张世荣,文良志,等.我国吡咯烷生物碱致肝窦阻塞综合征的临床特征分析[J].临床肝胆病杂志, 2018, 34(6): 1277-1281.
12
杨小倩,李骞,叶进,等.吡咯烷生物碱导致的肝窦阻塞综合征的MRI特点[J].临床消化病杂志, 2019, 31(3): 129-132.
13
Takashi M, Hironori H, Katsunobu O, et al. Phosphodiesterase Ⅲ inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space [J]. J Gastroenterol Hepatol, 2018, 33(4): 950-957.
14
朱成凯,张峰,诸葛宇征,等. 115例土三七致肝窦阻塞综合征的临床特点分析[J].中华消化杂志, 2017, 37(7): 448-452.
15
Petaja J, Pitkanen S, Vettenranta K. Serum tumor maker CA125 is an early and sensitive indicator of veno-occulusive disease in children undergoing bone marrow transplantiation [J]. Clin Res, 2000, 6(2): 531-535.
16
祖晓满,王春峰,张连峰,等.土三七致肝窦阻塞综合征53例临床特征与诊疗分析[J].中国实用医刊, 2019, 46(11): 4-8.
17
Li X, Yang X, Xu D, et al. Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome [J]. Clin Gastroenterol Hepatol, 2017, 15(6): 955-957.
18
俞傲,吕维富,周春泽,等.肝窦阻塞综合征CT和MRI表现[J].中国介入影像与治疗学, 2020, 17(4): 220-223.
19
Liu F, Rong X, Guo H, et al. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study [J]. BMC Gastroenterol, 2020, 20(1): 121-128.
20
Yang XQ, Ye J, Li X, et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes [J]. World J Gastroenterol, 2019, 25(28): 3753-3763.
[1] 秦菁, 马莉, 孝梦甦, 赵佳琳, 朱庆莉. 老年女性乳腺癌的临床特征及超声诊断价值[J]. 中华医学超声杂志(电子版), 2022, 19(02): 170-175.
[2] 廖怡, 罗蓉. 儿童脑型X-连锁肾上腺脑白质营养不良分析并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(02): 205-212.
[3] 马小睦, 肖剑春, 谢勇, 曲强. 腹膜后囊性病变65例临床特征及病理分析[J]. 中华普通外科学文献(电子版), 2021, 15(03): 203-206.
[4] 李雅丽, 薛敏君, 韩福. 38例肺隐球菌患者CT及临床特征分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 236-238.
[5] 许良媛, 马建民. 眼眶炎性肌纤维母细胞瘤的临床和基础研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(05): 310-315.
[6] 贾炜, 王海燕, 王茹, 陶勇, 黄轩. 原发性玻璃体视网膜淋巴瘤诊断面临的机遇和挑战[J]. 中华眼科医学杂志(电子版), 2022, 12(02): 65-69.
[7] 张沛, 何旭, 高春林, 夏正坤. 儿童ANCA相关性血管炎呼吸系统临床表现及影像学结果分析[J]. 中华临床医师杂志(电子版), 2022, 16(10): 953-958.
[8] 董振楠, 吴军政, 刘圣, 杨魏, 施海彬, 周卫忠. 经颈静脉肝内门体分流术治疗土三七所致肝窦阻塞综合征疗效分析[J]. 中华介入放射学电子杂志, 2023, 11(01): 25-29.
[9] 夏杰军, 徐翼, 牛传强, 刘珍银, 庞宁东. TIPS术治疗4岁儿童肝窦阻塞综合征1例[J]. 中华介入放射学电子杂志, 2022, 10(04): 456-458.
[10] 段红霞, 刘欣, 栗方芝, 张云起, 李瑞基, 庄金强. 羊水栓塞的诊断及治疗策略研究进展[J]. 中华诊断学电子杂志, 2023, 11(02): 133-135.
[11] 周红, 杨位霞. 进展性双侧延髓内侧梗死的临床特征[J]. 中华诊断学电子杂志, 2023, 11(01): 21-27.
[12] 李道胜, 班媛媛, 刘双. 朗格汉斯细胞组织细胞增生症临床病理特征分析[J]. 中华诊断学电子杂志, 2022, 10(04): 270-273.
[13] 周晓晴, 宁波, 令狐恩强. 肠系膜脂膜炎临床诊治的研究进展[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 267-270.
[14] 黄艳, 周美菊, 戴小娜, 柴岚, 郝桂锋, 袁放. 中老年风湿性多肌痛31例误诊和漏诊分析[J]. 中华老年病研究电子杂志, 2021, 08(04): 33-36.
[15] 郑茂凤, 时晶, 李婷, 徐筱青, 田金洲. 血管性帕金森综合征的临床特征及诊治研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(05): 347-350.
阅读次数
全文


摘要